Show simple item record

dc.contributor.authorLineen, James R
dc.contributor.authorKuliszewski, Michael
dc.contributor.authorDacouris, Niki
dc.contributor.authorLiao, Christine
dc.contributor.authorRudenko, Dmitriy
dc.contributor.authorDeva, Djeven P
dc.contributor.authorGoldstein, Marc
dc.contributor.authorLeong-Poi, Howard
dc.contributor.authorWald, Ron
dc.contributor.authorYan, Andrew T
dc.contributor.authorYuen, Darren A
dc.date.accessioned2015-09-01T17:33:52Z
dc.date.available2015-09-01T17:33:52Z
dc.date.issued2015-07-30
dc.identifier.citationCanadian Journal of Kidney Health and Disease. 2015 Jul 30;2(1):25
dc.identifier.urihttp://dx.doi.org/10.1186/s40697-015-0060-y
dc.identifier.urihttp://hdl.handle.net/10724/31822
dc.description.abstractAbstract Background Left ventricular hypertrophy (LVH) is commonly found in chronic dialysis (CD) recipients, and is associated with impaired microvascular cardiac perfusion and heart failure. In response to LVH and cardiac ischemia, early outgrowth pro-angiogenic cellS(EPCs) mobilize from the bone marrow to facilitate angiogenesis and endothelial repair. In the general population, EPC number and function correlate inversely with cardiovascular risk. In end-stage renal disease (ESRD), EPC number and function are generally reduced. Objectives To test whether left ventricular abnormalities retain their potent ability to promote EPC reparative responses in the setting of ESRD. Design Cross-sectional study. Setting St. Michael’s Hospital, Toronto, Ontario, Canada. Patients 47 prevalent chronic dialysis recipients. Measurements (1) circulating CD34+ and CD133+ EPC number, (2) cultured EPC migratory ability, in vitro differentiation potential, and apoptosis rate, and (3) cardiac magnetic resonance-measured LV mass, volume and ejection fraction. Methods Bivariate correlation analysis was performed with Spearman's rho test. Results Of the 47 patients (mean age: 54 ± 13 years), the mean delivered urea reduction was 74 ± 10 %. Mean LV mass was 123 ± 38 g. Circulating CD34+ and CD133+ EPCs represented 0.14 % (IQR: 0.05 – 0.29 %) and 0.05 % (IQR: 0.01 – 0.10 %) of peripheral blood mononuclear cells. There were no significant correlations between any EPC parameter and measures of LV mass or ejection fraction. Limitations Lack of a non-ESRD control population, and the inability to measure all parameters of EPC function due to limitations in blood sampling. Our inability to measure cardiac VEGF expression prevented an assessment of changes in cardiac EPC mobilization signals. Conclusions These data suggest that in ESRD, the reparative EPC response to cardiac hypertrophy may be blunted. Further investigation of the effects of uremia on EPC physiology and its relationship to cardiac injury are required.
dc.titleEarly outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study
dc.typeJournal Article
dc.date.updated2015-07-29T18:41:46Z
dc.language.rfc3066en
dc.rights.holderLineen et al.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record